Analytical Data
-
Gene name
SDK1
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z5N4
-
Expression Region
Pro104~Thr476
-
Molecular Weight
45kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDK1, or Striatin-Dependent Kinase 1, is a protein that plays a crucial role in various cellular processes, including signal transduction, cellular signaling pathways, and cytoskeletal organization. Research into the reorganization of SDK1 has gained momentum due to its implications in neurodevelopmental disorders and its potential involvement in different pathologies, such as cancer and cardiac diseases. Understanding the structural and functional properties of SDK1, particularly following its reorganization, is essential for elucidating its biological significance. Investigating the restructured forms of SDK1 can provide insights into its interactions with other proteins, regulatory mechanisms, and the impact of post-translational modifications. Furthermore, the study of SDK1 reorganization can contribute to the development of therapeutic strategies aimed at modulating its activity in diseases linked to aberrant cell signaling. By exploring the mechanisms underlying SDK1 reorganization, researchers hope to identify novel biomarkers and targets for intervention, ultimately enhancing our understanding of its role in maintaining cellular homeostasis and its dysregulation in disease contexts.
